Objective
To study the clinical application of the GOLD/GINA criteria and the Spanish guideline in the diagnosis of asthma-COPD overlap syndrome (ACOS).
Methods
Patients with stable COPD were consecutively enrolled in the study. Clinical data were collected, lung function with bronchodilator test and peak expiratory flow (PEF) were performed, and peripheral blood eosinophils, total IgE, and sputum inflammatory cells were measured. Those overlap with asthma were identified by the 2 different criteria, and the prevalence and features of ACOS were compared.
Results
Among 104 cases of stable COPD, 24 (23.1%) and 10 (9.6%) were identified as ACOS by the GOLD/GINA criteria and the Spanish guideline, respectively; the latter 10 cases were all included in the former 24. For the GOLD/GINA criteria, the most common features were symptoms triggered by exercise or emotions, variable airflow limitation, family history of asthma, and other allergic conditions. Mean diurnal PEF variation≥10% was evident in 11 cases (45.8%, 11/24), while bronchodilator test was positive in 16 cases (66.7%, 16/24). For the Spanish guideline, the most common features were diagnosis of asthma before 40, other allergic diseases, positive bronchodilator test on 2 occasions.
Conclusions
The GOLD/GINA criteria may be more sensitive for the diagnosis of ACOS, and do not need sophisticated lab tests, which may be more applicable for clinical use. The Spanish guideline is restrictive, and therefore may lead to under-diagnosis.
Citation:
LI Ruimin, XU Weihan, JIN Jianmin, ZHANG Yongxiang, SUN Yongchang. A preliminary study on the diagnosis of asthma-COPD overlap syndrome by different criteria. Chinese Journal of Respiratory and Critical Care Medicine, 2018, 17(6): 557-560. doi: 10.7507/1671-6205.201705034
Copy
Copyright © the editorial department of Chinese Journal of Respiratory and Critical Care Medicine of West China Medical Publisher. All rights reserved
1. |
Global strategy for asthma management and prevention. Revised 2014. Available at: http://www.ginasthma.org.
|
2. |
孙永昌. 哮喘-慢阻肺重叠综合征指南解读. 中国呼吸与危重监护杂志, 2014, 13(4): 325-329.
|
3. |
Miravitlles M, Soler-Cataluña JJ, Calle M, et al. A new approach to grading and treating COPD based on clinical phenotypes: summary of the Spanish COPD Guidelines (GesEPOC). Prim Care Respir J, 2013, 22(1): 117-121.
|
4. |
中华医学会呼吸病学分会慢性阻塞性肺疾病学组. 慢性阻塞性肺疾病诊治指南(2013 年修订版). 中华结核和呼吸杂志, 2013, 36(4): 255-264.
|
5. |
Vignola AM, Rennar SI, Hargreave FE, et al. Standardised methodology of sputum induction and processing: future directions. Eur Respir J, 2002, 20(Suppl 37): 51s-55s.
|
6. |
Barrecheguren M, Esquinas C, Miravitlles M. The asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): opportunities and challenges. Curr Opin Pulm Med, 2015, 21(1): 74-79.
|
7. |
Gibson PG, McDonald VM. Asthma-COPD overlap 2015: now we are six. Thorax, 2015, 70(7): 683-691.
|
8. |
Menezes AMB, Montes de Oca M, Pérez-Padilla R, et al. Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma. Chest, 2014, 145(2): 297-304.
|
9. |
Rubio MC, Casamor R, Miravitlles M. Identification and distribution of COPD phenotypes in clinical practice according to Spanish COPD Guidelines: the FENEPOC study. Int J COPD, 2017, 12: 2373-2383.
|
10. |
Cosio BG, Soriano JB, Lopez-Campos JL, et al. Defining the asthma-COPD overlap syndrome in a COPD cohort. Chest, 2016, 149(1): 45-52.
|
11. |
Jin JM, Liu XF, Sun YC. The prevalence of increased serum IgE and Aspergillus sensitization in patients with COPD and their association with symptoms and lung function. Respir Res, 2014, 15: 130.
|
12. |
Tamada T, Sugiura H, Takahashi T, et al. Biomarker-based detection of asthma-COPD overlap syndrome in COPD population. Int J COPD, 2015, 10: 2169-2176.
|
- 1. Global strategy for asthma management and prevention. Revised 2014. Available at: http://www.ginasthma.org.
- 2. 孙永昌. 哮喘-慢阻肺重叠综合征指南解读. 中国呼吸与危重监护杂志, 2014, 13(4): 325-329.
- 3. Miravitlles M, Soler-Cataluña JJ, Calle M, et al. A new approach to grading and treating COPD based on clinical phenotypes: summary of the Spanish COPD Guidelines (GesEPOC). Prim Care Respir J, 2013, 22(1): 117-121.
- 4. 中华医学会呼吸病学分会慢性阻塞性肺疾病学组. 慢性阻塞性肺疾病诊治指南(2013 年修订版). 中华结核和呼吸杂志, 2013, 36(4): 255-264.
- 5. Vignola AM, Rennar SI, Hargreave FE, et al. Standardised methodology of sputum induction and processing: future directions. Eur Respir J, 2002, 20(Suppl 37): 51s-55s.
- 6. Barrecheguren M, Esquinas C, Miravitlles M. The asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): opportunities and challenges. Curr Opin Pulm Med, 2015, 21(1): 74-79.
- 7. Gibson PG, McDonald VM. Asthma-COPD overlap 2015: now we are six. Thorax, 2015, 70(7): 683-691.
- 8. Menezes AMB, Montes de Oca M, Pérez-Padilla R, et al. Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma. Chest, 2014, 145(2): 297-304.
- 9. Rubio MC, Casamor R, Miravitlles M. Identification and distribution of COPD phenotypes in clinical practice according to Spanish COPD Guidelines: the FENEPOC study. Int J COPD, 2017, 12: 2373-2383.
- 10. Cosio BG, Soriano JB, Lopez-Campos JL, et al. Defining the asthma-COPD overlap syndrome in a COPD cohort. Chest, 2016, 149(1): 45-52.
- 11. Jin JM, Liu XF, Sun YC. The prevalence of increased serum IgE and Aspergillus sensitization in patients with COPD and their association with symptoms and lung function. Respir Res, 2014, 15: 130.
- 12. Tamada T, Sugiura H, Takahashi T, et al. Biomarker-based detection of asthma-COPD overlap syndrome in COPD population. Int J COPD, 2015, 10: 2169-2176.
Journal type citation(25)
1. | 刘思文,孙义田,贾同磊,张丽. 麻杏石甘汤治疗ACOS急性发作期的效果及对血清NGAL、Periostin水平的影响. 四川中医. 2024(11): 100-103 . Baidu Scholar | |
2. | 王倩倩,乔宝进. 孟鲁司特钠片联合沙美特罗替卡松吸入粉雾剂治疗哮喘-慢性阻塞性肺疾病重叠综合征的效果及对氧化应激指标、免疫功能的影响. 临床医学研究与实践. 2023(03): 39-41 . Baidu Scholar | |
3. | 郑玲,张春莲. 健康教育在多索茶碱联合特布他林治疗慢性阻塞性肺病患者护理中的应用. 国际护理学杂志. 2023(10): 1804-1807 . Baidu Scholar | |
4. | 吴杨,陈丽丽,陈营营,郝敬林. 肺功能测定鉴别支气管哮喘,慢阻肺及哮喘慢阻肺重叠综合征的临床价值分析. 系统医学. 2023(18): 92-95 . Baidu Scholar | |
5. | 焦春燕,焦咏梅,赵曌. 哮喘-慢阻肺重叠综合征患者免疫球蛋白、辅助性T细胞17和调节性T细胞与肺功能的相关性. 河南医学研究. 2022(05): 858-862 . Baidu Scholar | |
6. | 黄菲菲,秦继山. 中老年慢性阻塞性肺疾病临床特征与病情进展的相关性. 实用临床医药杂志. 2021(01): 45-49+53 . Baidu Scholar | |
7. | 钟朝彦. 补肺活血汤联合白三烯受体拮抗剂对哮喘合并慢阻肺患者气道炎症及肺功能的影响. 中外医学研究. 2021(10): 32-34 . Baidu Scholar | |
8. | 何宗林,颜田赅. 噻托溴铵联合布地奈德福莫特罗对哮喘-慢阻肺重叠综合征患者的疗效. 中外医学研究. 2021(12): 127-129 . Baidu Scholar | |
9. | 刘小敬,陈萍洁,刘坚. 孟鲁司特钠治疗哮喘-慢阻肺重叠综合征的疗效观察. 当代医学. 2021(26): 49-51 . Baidu Scholar | |
10. | 姚旭光,井沛沛,郭许飞. 慢阻肺合并哮喘肺功能的检测意义研究. 齐齐哈尔医学院学报. 2021(17): 1484-1487 . Baidu Scholar | |
11. | 刘柳娟. 慢阻肺患者接受中西医结合护理对心理状态及生活质量的改善效果. 智慧健康. 2021(25): 154-156+163 . Baidu Scholar | |
12. | 张江松,张颖,胡熠. ACOS患者FeNO水平与肺功能及血清EOS、CRP、ESR的相关性. 中华肺部疾病杂志(电子版). 2021(06): 819-821 . Baidu Scholar | |
13. | 苏伟. 噻托溴铵联合布地奈德对哮喘-慢性阻塞性肺疾病重叠综合征患者免疫及肺通气功能的影响. 中国当代医药. 2021(36): 44-46+50 . Baidu Scholar | |
14. | 邓虎,赵克明,隋艾凤,王国力,王丽娜,徐艳玲. 补益肺肾中药对哮喘—慢性阻塞性肺疾病重叠综合征患者的临床疗效. 世界中西医结合杂志. 2020(02): 220-223+291 . Baidu Scholar | |
15. | 汪夙兴. 呼出气一氧化氮水平与诱导痰嗜酸性粒细胞联合检测对哮喘-慢性阻塞性肺疾病重叠综合征、哮喘、慢性阻塞性肺疾病患者的诊断价值. 中国当代医药. 2020(05): 12-15 . Baidu Scholar | |
16. | 买智涛,姜明明,万善志. FeNO联合血清ECP、IgE检测对支气管哮喘的临床诊断价值. 分子诊断与治疗杂志. 2020(05): 625-628+633 . Baidu Scholar | |
17. | 明春玉,许光兰,赵媚,王光耀,陈青蓝,吴红英,陈小丽. 吸入激素联合噻托溴铵对比单用吸入激素治疗哮喘-慢阻肺重叠综合征有效性的Meta分析. 中国药房. 2020(11): 1364-1371 . Baidu Scholar | |
18. | 毛建华. 噻托溴铵联合沙美特罗替卡松对支气管哮喘合并慢性阻塞性肺疾病的疗效. 浙江实用医学. 2020(02): 79-81 . Baidu Scholar | |
19. | 张水旺,翁育清. 哮喘-慢阻肺重叠的诊治进展. 岭南急诊医学杂志. 2020(06): 667-668 . Baidu Scholar | |
20. | 林阅生. 哮喘-慢阻肺重叠综合征及慢阻肺患者的肺功能及临床特征比较. 当代医学. 2019(13): 26-28 . Baidu Scholar | |
21. | 美朗曲措,刘盼,陈青青. GOLD综合评估指标在高原慢阻肺患者中的应用探讨. 世界最新医学信息文摘. 2019(56): 80-81 . Baidu Scholar | |
22. | 王鹏,赵文,周金艳,多堂豹. 哮喘——慢阻肺重叠(ACO)中西医诊治的研究进展. 世界最新医学信息文摘. 2019(59): 66-68+71 . Baidu Scholar | |
23. | 夏晓辉. 异丙托溴铵联合沙美特罗替卡松治疗哮喘-慢性阻塞性肺疾病重叠综合征的疗效观察. 现代诊断与治疗. 2019(18): 3149-3150 . Baidu Scholar | |
24. | 陈慧暖,郭媛媛,洪敏俐,刘燕鸿,黄小华,洪春霖. 呼出气一氧化氮检测联合诱导痰嗜酸性粒细胞计数对ACO的诊断效能分析. 国际检验医学杂志. 2019(21): 2613-2616 . Baidu Scholar | |
25. | 刘洋,于盼,韩金花,孙丰云,郑彩霞. 清肺定喘汤联合西药对哮喘-慢性阻塞性肺疾病重叠综合征患者肺功能、呼出气冷凝液及FeNO的影响. 上海中医药大学学报. 2019(06): 27-32 . Baidu Scholar | |
Other types of references(3)
1. | 王鹏. 三桔咳喘口服液在治疗哮喘—慢阻肺重叠(ACO)急性发作期中的临床疗效观察[D]. 成都中医药大学. 2019. Baidu Scholar | |
2. | 马建科. 胸部定量CT“肺气肿指数”在哮喘—慢阻肺重叠诊断中的价值研究[D]. 甘肃中医药大学. 2019. Baidu Scholar | |
3. | 张晓晋. 肺胀平丸联合沙美特罗替卡松粉吸入剂治疗哮喘慢阻肺重叠(ACO)脾肾阳虚、痰瘀阻肺证的临床观察[D]. 甘肃中医药大学. 2023. Baidu Scholar | |